Kobayashi Naoya, Noguchi Hirofumi, Westerman Karen A, Watanabe Takamasa, Matsumura Toshihisa, Totsugawa Toshinori, Fujiwara Toshiyoshi, Leboulch Philippe, Tanaka Noriaki
First Department of Surgery, Okayama University Medical School, 2-5-1 Shikata-cho, Okayama 700-8558, Japan.
Harvard-Massachusetts Institute of Technology, Division of Health Sciences and Technology, Cambridge, MA 02139.
Cell Transplant. 2001 May/Jul;10(4-5):377-381. doi: 10.3727/000000001783986585.
Current clinical reports have indicated that hepatocyte transplantation (HTX) could be used in patients with liver failure and in children with liver-based metabolic diseases. One of the major limiting factors of HTX is a serious shortage of donor livers for hepatocyte isolation. To address this issue, we immortalized adult human hepatocytes with a retroviral vector SSR#69 expressing the genes of simian virus 40 large T antigen and herpes simplex virus-thymidine kinase simultaneously. One of the resulting clones, NKNT-3, grew steadily in chemically defined serum-free medium without any obvious crisis and showed the gene expression of differentiated liver functions. Under the administration of 5 μM ganciclovir, NKNT-3 cells stopped proliferation and died in in vitro experiments. We have established a tightly regulated immortal human hepatocyte cell line. The cells could allow the need for immediate availability of consistent and functionally uniform cells in sufficient quantity and adequate quality.